These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9120512)

  • 1. Long-term cost-effectiveness of alternative management strategies for patients with life-threatening ventricular arrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring (ESVEM) Investigators.
    Hlatky MA; Boothroyd DB; Johnstone IM; Marcus FI; Hahn E; Hartz V; Mason JW
    J Clin Epidemiol; 1997 Feb; 50(2):185-93. PubMed ID: 9120512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Electrophysiology Study Versus Electrocardiographic Monitoring Trial: its programmed stimulation protocol may introduce bias when assessing long-term antiarrhythmic drug therapy.
    Biblo LA; Carlson MD; Waldo AL
    J Am Coll Cardiol; 1995 Jun; 25(7):1601-4. PubMed ID: 7759711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of the Electrophysiologic Study versus Electrocardiographic Monitoring trial for controlling ventricular tachycardia and fibrillation.
    Reiffel JA
    Am J Cardiol; 1996 Aug; 78(4A):34-40. PubMed ID: 8780327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance and incidence of concordance of drug efficacy predictions by Holter monitoring and electrophysiological study in the ESVEM Trial. Electrophysiologic Study Versus Electrocardiographic Monitoring.
    Reiter MJ; Mann DE; Reiffel JE; Hahn E; Hartz V
    Circulation; 1995 Apr; 91(7):1988-95. PubMed ID: 7895357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sotalol for ventricular tachyarrhythmias: beta-blocking and class III contributions, and relative efficacy versus class I drugs after prior drug failure. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring.
    Reiffel JA; Hahn E; Hartz V; Reiter MJ
    Am J Cardiol; 1997 Apr; 79(8):1048-53. PubMed ID: 9114762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of initial therapy in the Electrophysiological Study Versus ECG Monitoring trial (ESVEM).
    Omoigui NA; Marcus FI; Mason JW; Hahn EA; Hartz VL; Hlatky MA
    Circulation; 1995 Feb; 91(4):1070-6. PubMed ID: 7850943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of sotalol and class I antiarrhythmic agents in patients with ventricular tachycardia or fibrillation: results of the Electrophysiology Study Versus Electrocardiographic Monitoring (ESVEM) Trial.
    Klein RC
    Eur Heart J; 1993 Nov; 14 Suppl H():78-84. PubMed ID: 8293756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic Study versus Electrocardiographic Monitoring (ESVEM): a critical appraisal.
    Prystowsky EN
    Control Clin Trials; 1996 Jun; 17(3 Suppl):28S-36S. PubMed ID: 8877265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost and efficacy analysis in the ESVEM trial: implications for diagnosis and therapy for ventricular tachyarrhythmias.
    Hlatky MA
    Prog Cardiovasc Dis; 1996; 38(5):371-6. PubMed ID: 8604441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of reproducibility of baseline arrhythmia induction on drug efficacy predictions and outcome in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial.
    Mann DE; Hartz V; Hahn EA; Reiter MJ
    Am J Cardiol; 1997 Dec; 80(11):1448-52. PubMed ID: 9399720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ESVEM trial. Electrophysiologic Study Versus Electrocardiographic Monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. The ESVEM Investigators.
    Circulation; 1989 Jun; 79(6):1354-60. PubMed ID: 2655967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of drug efficacy predictions by Holter monitoring in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. ESVEM Investigators.
    Reiter MJ; Karagounis LA; Mann DE; Reiffel JA; Hahn E; Hartz V
    Am J Cardiol; 1997 Feb; 79(3):315-22. PubMed ID: 9036751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sotalol: An important new antiarrhythmic.
    Anderson JL; Prystowsky EN
    Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of predicted efficacy of antiarrhythmic drugs in the electrophysiologic study versus electrocardiographic monitoring trial. The ESVEM Investigators.
    Circulation; 1993 Feb; 87(2):323-9. PubMed ID: 8425281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A perspective on the ESVEM trial current knowledge: sotalol should not be the first-line agent in the management of ventricular arrhythmias.
    Garan H
    Prog Cardiovasc Dis; 1996; 38(6):455-6. PubMed ID: 8638026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of Holter ECG guided therapy for ventricular arrhythmias: the ESVEM trial.
    Lazzara R
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):473-7. PubMed ID: 7513876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ESVEM trial: impact on treatment of ventricular tachyarrhythmias. Electrophysiologic Study Versus Electrocardiographic Monitoring.
    Reiter MJ
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):468-77. PubMed ID: 9058850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A summary and assessment of the findings and conclusions of the ESVEM trial.
    Mason JW; Marcus FI; Bigger JT; Lazzara R; Reiffel JA; Reiter MJ; Mann D
    Prog Cardiovasc Dis; 1996; 38(5):347-58. PubMed ID: 8604439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.